🧠 Watchlist Winners: Copy Legendary Investors' Portfolios in One ClickCOPY FOR FREE

Astellas Pharma Inc. (4503)

Tokyo
Currency in JPY
Disclaimer
1,705.0
-84.5(-4.72%)
Closed
4503 Scorecard
Full Analysis
Has raised its dividend for 9 consecutive years
High dividend Yield
Fair Value
Day's Range
1,698.51,805.0
52 wk Range
1,426.02,238.0
Bid/Ask
1,700.00 / 1,705.50
Prev. Close
1,789.5
Open
1,784.5
Day's Range
1,698.5-1,805
52 wk Range
1,426-2,238
Volume
11,212,800
Average Vol. (3m)
7,045,217
1-Year Change
-19.27%
Fair Value
Unlock
Fair Value Upside
Unlock
4503 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
1,950.0
Upside
+14.4%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

Astellas Pharma Inc. Company Profile

Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf and Advagraf/Graceptor/ASTAGRAF XL immunosuppressants. Th company has a research collaboration with Vivtex Corporation to evaluate Vivtex’s GI-ORIS screening and formulation platform technology to support the development of novel and oral versions of a therapeutic candidate provided by Astellas; and a partnership agreement with Roche Diabetes Care Japan Co., Ltd. to develop and commercialize integrated diabetes self-management solution. The company was founded in 1923 and is headquartered in Tokyo, Japan.

Employees
14484
Market
Japan

Compare 4503 to Peers and Sector

Metrics to compare
4503
Peers
Sector
Relationship
P/E Ratio
149.1x17.7x−0.6x
PEG Ratio
−1.810.470.00
Price / Book
1.9x1.5x2.6x
Price / LTM Sales
1.9x2.1x3.1x
Upside (Analyst Target)
15.2%8.3%57.6%
Fair Value Upside
Unlock15.8%7.3%Unlock

People Also Watch

6,720.0
4519
-1.64%
5,135.0
4568
+0.86%
5,466.0
2502
-0.35%

FAQ

What Is the Astellas Pharma Inc. (4503) Stock Price Today?

The Astellas Pharma Inc. stock price today is 1,705.00

What Stock Exchange Does Astellas Pharma Inc. Trade On?

Astellas Pharma Inc. is listed and trades on the Tokyo stock exchange.

What Is the Stock Symbol for Astellas Pharma Inc.?

The stock symbol for Astellas Pharma Inc. is "4503."

Does Astellas Pharma Inc. Pay Dividends? What’s The Current Dividend Yield?

The dividend yield is 4.02%.

What Is the Astellas Pharma Inc. Market Cap?

As of today, Astellas Pharma Inc. market cap is 3.06T.

What is Astellas Pharma Inc. Earnings Per Share?

The Astellas Pharma Inc. EPS is 12.01.

What Is the Next Astellas Pharma Inc. Earnings Date?

Astellas Pharma Inc. will release its next earnings report on Oct 31, 2024.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.